Clopidogrel and the enzyme CYP2C19
Clopidogrel is a drug that first needs to be metabolised into an active component within the body. The enzyme CYP2C19 plays an important role in this process.
The activity of this enzyme can, however, vary considerably depending on your genetic predisposition, which means the availability of the active component of clopidogrel can also differ from person to person.
Information about your genetic predisposition may therefore provide grounds to opt for an alternative anticoagulant.
Read more about The enzyme CYP2C19 »